Breadcrumb AMCP.org Corporate Opportunities National Meetings Calendar Leniolisib: A Novel Drug Being Investigated for Treatment of APDS, a Rare Primary Immunodeficiency Leniolisib: A Novel Drug Being Investigated for Treatment of APDS, a Rare Primary Immunodeficiency Tweet this pagePost this page on FacebookPost this page on LinkedInEmail this pagePrint this page Date: Thursday, September 15, 2022, 2-3pm ETEvent Type: WebinarsPrice: Member: Free Non-Member: FreeRegister Today